Britton et al., 1985 - Google Patents
Diagnosing suspected stroke: a cost-effectiveness analysisBritton et al., 1985
- Document ID
- 1483964902167333656
- Author
- Britton M
- Jonsson E
- Marké L
- Murray V
- Publication year
- Publication venue
- International Journal of Technology Assessment in Health Care
External Links
Snippet
Acute cerebrovascular disease (CBVD) has an annual incidence of 100–300 per 100,000 inhabitants in the industrialized countries (1, 2). CBVD occurs mainly in the elderly. Acute mortality is around 15%. Disablement and decreased quality of life are common …
- 238000004458 analytical method 0 title description 5
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/412—Detecting or monitoring sepsis
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chauveau et al. | Intracranial aneurysms in autosomal dominant polycystic kidney disease | |
| Fick et al. | The spectrum of autosomal dominant polycystic kidney disease in children. | |
| Tucker et al. | Early diagnostic efficiency of cardiac troponin I and troponin T for acute myocardial infarction | |
| Weiss et al. | Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage | |
| Anstey et al. | The role of volumetric MRI in understanding mild cognitive impairment and similar classifications | |
| McCullough et al. | Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain | |
| McMANUS et al. | Assessment of borderline symptomatology in hospitalized adolescents | |
| Kontos et al. | Evaluation of the emergency department chest pain patient | |
| Yavuz et al. | Hippocampal atrophy correlates with the severity of cognitive decline | |
| Woo et al. | Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting? | |
| Viberti et al. | St Vincent Declaration, 1994: guidelines for the prevention of diabetic renal failure | |
| Goerss et al. | Frequency of familial dilated cardiomyopathy | |
| Hobson et al. | Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS) | |
| JP2004529351A (en) | Improvements to the diagnosis of acute myocardial infarction and other clinical conditions | |
| EP1899726B1 (en) | Methods for diagnosing and treating cerebrovascular events based on nr2 peptides | |
| US8999659B2 (en) | Body fluid BIN1 as a marker of cardiac health | |
| Britton et al. | Diagnosing suspected stroke: a cost-effectiveness analysis | |
| US20050021235A1 (en) | Method and system for optically performing an assay to determine a medical condition | |
| Swanwick et al. | Utility of ischemic scores in the differential diagnosis of Alzheimer's disease and ischemic vascular dementia | |
| Auckland, Newcastle and Perth MONICA Centres | Risk‐factor levels and mortality of ischaemic heart disease in three Australasian centres | |
| US8192997B2 (en) | Methods of predicting and treating adverse cardiac events | |
| Yonge | Magnetic resonance muscle studies: implications for psychiatry | |
| Heath et al. | Failure of the Hong Kong criteria to predict the severity of acute pancreatitis | |
| RU2823482C1 (en) | Method for assessing risk of developing chronic kidney disease in patients with stage ii hypertension | |
| RU2822812C1 (en) | Method for assessing risk of developing chronic kidney disease in men with stage ii hypertension |